Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy

NCT07831746 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT07831746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07831746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy
Lead sponsor
UMC Utrecht
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
April 1, 2027
Completion date
September 1, 2032
Enrollment
162 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hie - hypoxic - ischemic encephalopathy, hypoxic-ischemic brain injury, pais, perinatal arterial ischemic stroke, perinatal asphyxia